Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.

“MedCity news is a peerless national resource for those of us who really want to stay on top the very latest news in healthcare from incumbents to startups. ”

Elliot Menschik, DreamIt Ventures partner; Venturef0rth founder; Penn professor

Sign up for our daily newsletter

Abuse-deterrent painkiller fails study goal, drugmaker Acura’s shares fall

4:42 pm by | 0 Comments

(Reuters) - Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing likability among abusers, sending its shares down 34 percent in after-hours trading.

The study showed that Acura's tablet, Aversion H&A, had a slighter lower measure of liking when compared with the generic hydrocodone/acetaminophen tablet.

The tablet was tested for potential abuse by snorting.

The company said it expects the submission of a marketing approval application to be delayed.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.